Description:

Southwest Oncology Group S0600 Treatment Form Irinotecan and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic Colorectal Cancer That Progressed During First-Line Therapy Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=5DA30D89-61BB-0FC6-E040-BB89A643170F

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=5DA30D89-61BB-0FC6-E040-BB89A643170F

Keywords:
Versions (2) ▾
  1. 8/27/12
  2. 1/9/15
Uploaded on:

January 9, 2015

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Colorectal Cancer NCT00499369 Treatment - Southwest Oncology Group S0600 Treatment Form - 2813273v1.0

No Instruction available.

  1. StudyEvent: Southwest Oncology Group S0600 Treatment Form
    1. No Instruction available.
Header
Status
Vital Status
Has the patient progressed per the definition of Section 10.0 of the protocol
Treatment
Assigned Treatment Arm
Concurrent chemotherapy
Kg
Were there any dose modifications or additions/omissions to protocol treatment?
Was G-CSF received
Units
Ccrr Module For Southwest Oncology Group S0303 Treatment Form - Arm 1

Similar models